Pattern recognition and biomarker validation using quantitative ¹H-NMR-based metabolomics

References

• Bundy JG, Spurgeon DJ, Svendsen C et al. Earthworm species of the genus Eisenia can be phenotypically differentiated by metabolic profiling. FEBS Lett.521, 115–120 (2002).
   PubMed Web of Science ®Google Scholar
• Gavaghan CL, Holmes E, Lenz E et al. An NMR-based metabonomic approach to investigate the biochemical consequences of genetic strain differences: application to the C57BL10J and Alpk:ApfCD mouse. FEBS Lett.484, 169–174 (2000).
   PubMed Web of Science ®Google Scholar
• Griffin JL. Metabolic profiles to define the genome: can we hear the phenotypes? Philos. Trans. R. Soc. Lond. B. Biol. Sci.359, 857–871 (2004).
   PubMed Web of Science ®Google Scholar
• Nicholson JK, Wilson ID. Opinion: understanding ‘global’ systems biology: metabonomics and the continuum of metabolism. Nat. Rev. Drug Discov.2, 668–676 (2003).
   PubMed Web of Science ®Google Scholar
• Griffin JL, Shockcor JP. Metabolic profiles of cancer cells. Nat. Rev. Cancer4, 551–561 (2004).
   PubMed Web of Science ®Google Scholar
• Nicholson JK, Lindon JC, Holmes E. ‘Metabonomics’: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica29, 1181–1189 (1999).
   PubMed Web of Science ®Google Scholar
• Wishart DS. Metabolomics: the principles and potential applications to transplantation. Am. J. Transplant.5, 2814–2820 (2005).
   PubMed Web of Science ®Google Scholar
• Pelczer I. High-resolution NMR for metabomics. Curr. Opin. Drug Discov. Devel.8, 127–133 (2005).
   PubMedGoogle Scholar
• Stoyanova R, Brown TR. NMR spectral quantitation by principal component analysis. III. A generalized procedure for determination of lineshape variations. J. Magn. Reson.154, 163–175 (2002).
   PubMedGoogle Scholar
• German JB, Roberts MA, Watkins SM. Personal metabolomics as a next generation nutritional assessment. J. Nutr.133, 4260–4266 (2003).
   PubMed Web of Science ®Google Scholar
• Keun HC. Metabonomic modeling of drug toxicity. Pharmacol. Ther.109, 92–106 (2006).
   PubMed Web of Science ®Google Scholar
• Robertson DG. Metabonomics in toxicology: a review. Toxicol. Sci.85, 809–822 (2005).
   PubMed Web of Science ®Google Scholar
• Rochfort S. Metabolomics reviewed: a new ‘omics’ platform technology for systems biology and implications for natural products research. J. Nat. Prod.68, 1813–1820 (2005).
   PubMed Web of Science ®Google Scholar
• Lenz EM, Bright J, Knight R et al. Cyclosporin A-induced changes in endogenous metabolites in rat urine: a metabonomic investigation using high field 1H NMR spectroscopy, HPLC-TOF/MS and chemometrics. J. Pharm. Biomed. Anal.35, 599–608 (2004).
   PubMed Web of Science ®Google Scholar
• Serkova N, Klawitter J, Niemann CU. Organ-specific response to inhibition of mitochondrial metabolism by cyclosporine in the rat. Transpl. Int.16, 748–755 (2003).
   PubMed Web of Science ®Google Scholar
• Kleno TG, Kiehr B, Baunsgaard D, Sidelmann UG. Combination of ‘omics’ data to investigate the mechanism(s) of hydrazine-induced hepatotoxicity in rats and to identify potential biomarkers. Biomarkers9, 116–138 (2004).
   PubMed Web of Science ®Google Scholar
• Waters NJ, Waterfield CJ, Farrant RD et al. Metabonomic deconvolution of embedded toxicity: application to thioacetamide hepato- and nephrotoxicity. Chem. Res. Toxicol.18, 639–654 (2005).
   PubMed Web of Science ®Google Scholar
• Conrads TP, Fusaro VA, Ross S et al. High-resolution serum proteomic features for ovarian cancer detection. Endocr. Relat. Cancer11, 163–178 (2004).
   PubMed Web of Science ®Google Scholar
• Conrads TP, Zhou M, Petricoin EF 3rd et al. Cancer diagnosis using proteomic patterns. Expert Rev. Mol. Diagn.3, 411–420 (2003).
   PubMed Web of Science ®Google Scholar
• Petricoin EF, Ardekani AM, Hitt BA et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet359, 572–577 (2002).
   PubMed Web of Science ®Google Scholar
• Hirsch J, Hansen KC, Choi S et al. Warm ischemia-induced alterations in oxidative and inflammatory proteins in hepatic Kupffer cells in rats. Mol. Cell. Proteomics5, 979–986 (2006).
   PubMedGoogle Scholar
• Villanueva J, Shaffer DR, Philip J et al. Differential exoprotease activities confer tumor-specific serum peptidome patterns. J. Clin. Invest.116, 271–284 (2006).
   PubMed Web of Science ®Google Scholar
• Lindon JC, Keun HC, Ebbels TM et al. The Consortium for Metabonomic Toxicology (COMET): aims, activities and achievements. Pharmacogenomics6, 691–699 (2005).
   PubMed Web of Science ®Google Scholar
• Schmidt C. Metabolomics takes its place as latest up-and-coming ‘omic’ science. J. Natl Cancer Inst.96, 732–734 (2004).
   PubMedGoogle Scholar
• Azmi J, Connelly J, Holmes E et al. Characterization of the biochemical effects of 1-nitronaphthalene in rats using global metabolic profiling by NMR spectroscopy and pattern recognition. Biomarkers10, 401–416 (2005).
   PubMed Web of Science ®Google Scholar
• Feng J, Li X, Pei F et al.1H-NMR analysis for metabolites in serum and urine from rats administrated chronically with La(NO3)3. Anal. Biochem.301, 1–7 (2002).
   PubMed Web of Science ®Google Scholar
• Mortishire-Smith RJ, Skiles GL, Lawrence JW et al. Use of metabonomics to identify impaired fatty acid metabolism as the mechanism of a drug-induced toxicity. Chem. Res. Toxicol.17, 165–173 (2004).
   PubMed Web of Science ®Google Scholar
• Engelke UF, Kremer B, Kluijtmans LA et al. NMR spectroscopic studies on the late onset form of 3-methylglutaconic aciduria type I and other defects in leucine metabolism. NMR Biomed.19, 271–278 (2006).
   PubMedGoogle Scholar
• Moolenaar SH, Gohlich-Ratmann G, Engelke UF et al. beta-Ureidopropionase deficiency: a novel inborn error of metabolism discovered using NMR spectroscopy on urine. Magn. Reson. Med.46, 1014–1017 (2001).
   PubMedGoogle Scholar
• Wevers RA, Engelke UF, Moolenaar SH et al.1H-NMR spectroscopy of body fluids: inborn errors of purine and pyrimidine metabolism. Clin. Chem.45, 539–548 (1999).
   PubMed Web of Science ®Google Scholar
• Hauet T, Baumert H, Gibelin H et al. Citrate, acetate and renal medullary osmolyte excretion in urine as predictor of renal changes after cold ischaemia and transplantation. Clin. Chem. Lab. Med.38, 1093–1098 (2000).
   PubMedGoogle Scholar
• Hauet T, Baumert H, Gibelin H et al. Noninvasive monitoring of citrate, acetate, lactate, and renal medullary osmolyte excretion in urine as biomarkers of exposure to ischemic reperfusion injury. Cryobiology41, 280–291 (2000).
   PubMed Web of Science ®Google Scholar
• Fuller TF, Serkova N, Niemann CU, Freise CE. Influence of donor pretreatment with N-acetylcysteine on ischemia/reperfusion injury in rat kidney grafts. J. Urol.171, 1296–1300 (2004).
   PubMed Web of Science ®Google Scholar
• Niemann CU, Hirose R, Liu T et al. Ischemic preconditioning improves energy state and transplantation survival in obese Zucker rat livers. Anesth. Analg.101, 1577–1583 (2005).
   PubMedGoogle Scholar
• Serkova N, Fuller TF, Klawitter J et al. H-NMR-based metabolic signatures of mild and severe ischemia/reperfusion injury in rat kidney transplants. Kidney Int.67, 1142–1151 (2005).
   PubMed Web of Science ®Google Scholar
• Whitfield PD, German AJ, Noble PJ. Metabolomics: an emerging post-genomic tool for nutrition. Br. J. Nutr.92, 549–555 (2004).
   PubMed Web of Science ®Google Scholar
• Serkova NJ, Jackman M, Brown JL et al. Metabolic profiling of livers and blood from obese Zucker rats. J. Hepatol.44, 956–962 (2006).
   PubMed Web of Science ®Google Scholar
• Azmi J, Griffin JL, Shore RF et al. Chemometric analysis of biofluids following toxicant induced hepatotoxicity: a metabonomic approach to distinguish the effects of 1-naphthylisothiocyanate from its products. Nat. Rev. Cancer35, 839–852 (2005).
   Google Scholar
• Dabos KJ, Newsome PN, Parkinson JA et al. A biochemical prognostic model of outcome in paracetamol-induced acute liver injury. Transplantation80, 1712–1717 (2005).
   PubMed Web of Science ®Google Scholar
• Coen M, Lenz EM, Nicholson JK et al. An integrated metabonomic investigation of acetaminophen toxicity in the mouse using NMR spectroscopy. Chem. Res. Toxicol.16, 295–303 (2003).
   PubMed Web of Science ®Google Scholar
• Maddox JF, Luyendyk JP, Cosma GN et al. Metabonomic evaluation of idiosyncrasy-like liver injury in rats cotreated with ranitidine and lipopolysaccharide. Toxicol. Appl. Pharmacol.212, 35–44 (2006).
   PubMed Web of Science ®Google Scholar
• Serkova NJ, Christians U. Biomarkers for toxicodynamic monitoring of immunosuppressants: NMR-based quantitative metabonomics of the blood. Ther. Drug Monit.27, 733–737 (2005).
   PubMed Web of Science ®Google Scholar
• Bathen TF, Engan T, Krane J, Axelson D. Analysis and classification of proton NMR spectra of lipoprotein fractions from healthy volunteers and patients with cancer or CHD. AntiCancer Res.20, 2393–2408 (2000).
   PubMedGoogle Scholar
• Odunsi K, Wollman RM, Ambrosone CB et al. Detection of epithelial ovarian cancer using 1H-NMR-based metabonomics. Int. J. Cancer113, 782–788 (2005).
   PubMed Web of Science ®Google Scholar
• Brindle JT, Antti H, Holmes E et al. Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics. Nat. Med.8, 1439–1444 (2002).
   PubMed Web of Science ®Google Scholar
• Averna TA, Kline EE, Smith AY, Sillerud LO. A decrease in 1H nuclear magnetic resonance spectroscopically determined citrate in human seminal fluid accompanies the development of prostate adenocarcinoma. J. Urol.173, 433–438 (2005).
   PubMed Web of Science ®Google Scholar
• Melendez HV, Ahmadi D, Parkes HG et al. Proton nuclear magnetic resonance analysis of hepatic bile from donors and recipients in human liver transplantation. Transplantation72, 855–860 (2001).
   PubMedGoogle Scholar
• Paczkowska A, Toczylowska B, Nyckowski P et al. High-resolution 1H nuclear magnetic resonance spectroscopy analysis of bile samples obtained from a patient after orthotopic liver transplantation: new perspectives. Transplant. Proc.35, 2278–2280 (2003).
   PubMedGoogle Scholar
• Dunne VG, Bhattachayya S, Besser M et al. Metabolites from cerebrospinal fluid in aneurysmal subarachnoid haemorrhage correlate with vasospasm and clinical outcome: a pattern-recognition 1H NMR study. NMR Biomed.18, 24–33 (2005).
   PubMed Web of Science ®Google Scholar
• Kurz A, Riemenschneider M, Wallin A. Potential biological markers for cerebrovascular disease. Int. Psychogeriatr.15(Suppl. 1), 89–97 (2003).
   PubMedGoogle Scholar
• Hashimoto K, Engberg G, Shimizu E et al. Elevated glutamine/glutamate ratio in cerebrospinal fluid of first episode and drug naive schizophrenic patients. BMC Psychiatry5, 6 (2005).
   PubMed Web of Science ®Google Scholar
• Garrod S, Humpher E, Connor SC et al. High-resolution (1)H NMR and magic angle spinning NMR spectroscopic investigation of the biochemical effects of 2-bromoethanamine in intact renal and hepatic tissue. Magn. Reson. Med.45, 781–790 (2001).
   PubMed Web of Science ®Google Scholar
• Bollard ME, Garrod S, Holmes E et al. High-resolution (1)H and (1)H-(13)C magic angle spinning NMR spectroscopy of rat liver. Magn. Reson. Med.44, 201–207 (2000).
   PubMedGoogle Scholar
• Cheng LL, Wu C, Smith MR, Gonzalez RG. Non-destructive quantitation of spermine in human prostate tissue samples using HRMAS 1H NMR spectroscopy at 9.4 T. FEBS Lett.494, 112–116 (2001).
   PubMed Web of Science ®Google Scholar
• Martinez-Granados B, Monleon D, Martinez-Bisbal MC et al. Metabolite identification in human liver needle biopsies by high-resolution magic angle spinning 1H NMR spectroscopy. NMR Biomed.19, 90–100 (2006).
   PubMed Web of Science ®Google Scholar
• Griffin JL. Metabonomics: NMR spectroscopy and pattern recognition analysis of body fluids and tissues for characterisation of xenobiotic toxicity and disease diagnosis. Curr. Opin. Chem. Biol.7, 648–654 (2003).
   PubMed Web of Science ®Google Scholar
• Lenz EM, Bright J, Wilson ID et al. A 1H NMR-based metabonomic study of urine and plasma samples obtained from healthy human subjects. J. Pharm. Biomed. Anal.33, 1103–1115 (2003).
   PubMed Web of Science ®Google Scholar
• Tang H, Wang Y, Nicholson JK, Lindon JC. Use of relaxation-edited one-dimensional and two dimensional nuclear magnetic resonance spectroscopy to improve detection of small metabolites in blood plasma. Anal. Biochem.325, 260–272 (2004).
   PubMed Web of Science ®Google Scholar
• Daykin CA, Foxall PJ, Connor SC et al. The comparison of plasma deproteinization methods for the detection of low-molecular-weight metabolites by (1)H nuclear magnetic resonance spectroscopy. Anal. Biochem.304, 220–230 (2002).
   PubMed Web of Science ®Google Scholar
• Le Belle JE, Harris NG, Williams SR, Bhakoo KK. A comparison of cell and tissue extraction techniques using high-resolution 1H-NMR spectroscopy. NMR Biomed.15, 37–44 (2002).
   PubMed Web of Science ®Google Scholar
• Behrends M, Hirose R, Serkova NJ et al. Mild hypothermia reduces the inflammatory response and hepatic ischemia/ reperfusion injury in rats. Liver Int.26, 734–741 (2006).
   Google Scholar
• Serkova N, Bendrick-Peart J, Alexander B, Tissot van Patot MC. Metabolite concentrations in human term placentae and their changes due to delayed collection after delivery. Placenta24, 227–235 (2003).
   PubMed Web of Science ®Google Scholar
• Silvestre V, Goupry S, Trierweiler M et al. Determination of substrate and product concentrations in lactic acid bacterial fermentations by proton NMR using the ERETIC method. Anal. Chem.73, 1862–1868 (2001).
   PubMedGoogle Scholar
• Loening NM, Chamberlin AM, Zepeda AG et al. Quantification of phosphocholine and glycerophosphocholine with 31P edited 1H NMR spectroscopy. NMR Biomed.18, 413–420 (2005).
   PubMed Web of Science ®Google Scholar
• Zektzer AS, Swanson MG, Jarso S et al. Improved signal to noise in high-resolution magic angle spinning total correlation spectroscopy studies of prostate tissues using rotor-synchronized adiabatic pulses. Magn. Reson. Med.53, 41–48 (2005).
   PubMedGoogle Scholar
• Holmes E, Antti H. Chemometric contributions to the evolution of metabonomics: mathematical solutions to characterising and interpreting complex biological NMR spectra. Analyst127, 1549–1557 (2002).
   PubMed Web of Science ®Google Scholar
• Holmes E, Nicholls AW, Lindon JC et al. Chemometric models for toxicity classification based on NMR spectra of biofluids. Chem. Res. Toxicol.13, 471–478 (2000).
   PubMed Web of Science ®Google Scholar
• Sinha G. Drug research. Trying to catch troublemakers with a metabolic profile. Science310, 965–966 (2005).
   PubMed Web of Science ®Google Scholar
• Beckwith-Hall BM, Nicholson JK, Nicholls AW et al. Nuclear magnetic resonance spectroscopic and principal components analysis investigations into biochemical effects of three model hepatotoxins. Chem. Res. Toxicol.11, 260–272 (1998).
   PubMed Web of Science ®Google Scholar
• Nicholls AW, Holmes E, Lindon JC et al. Metabonomic investigations into hydrazine toxicity in the rat. Chem. Res. Toxicol.14, 975–987 (2001).
   PubMed Web of Science ®Google Scholar
• Agutter PS, Malone PC, Wheatley DN. Intracellular transport mechanisms: a critique of diffusion theory. J. Theor. Biol.176, 261–272 (1995).
   PubMedGoogle Scholar
• Heijne WH, Lamers RJ, van Bladeren PJ et al. Profiles of metabolites and gene expression in rats with chemically induced hepatic necrosis. Toxicol. Pathol.33, 425–433 (2005).
   PubMed Web of Science ®Google Scholar
• Wang Q, Jiang Y, Wu C et al. Study of a novel indolin-2-ketone compound Z24 induced hepatotoxicity by NMR-spectroscopy-based metabonomics of rat urine, blood plasma, and liver extracts. Toxicol. Appl. Pharmacol. (2006) (Epub ahead of print).
   Google Scholar
• Nicholson JK, Connelly J, Lindon JC, Holmes E. Metabonomics: a platform for studying drug toxicity and gene function. Nat. Rev. Drug Discov.1, 153–161 (2002).
   PubMed Web of Science ®Google Scholar
• Serkova N, Donohoe P, Gottschalk S et al. Comparison of the effects of cyclosporin a on the metabolism of perfused rat brain slices during normoxia and hypoxia. J. Cereb. Blood Flow Metab.22, 342–352 (2002).
   PubMed Web of Science ®Google Scholar
• Hauet T, Gibelin H, Godart C et al. Kidney retrieval conditions influence damage to renal medulla: evaluation by proton nuclear magnetic resonance (NMR) spectroscopy. Clin. Chem. Lab. Med.38, 1085–1092 (2000).
   PubMedGoogle Scholar
• Hauet T, Gibelin H, Richer JP et al. Influence of retrieval conditions on renal medulla injury: evaluation by proton NMR spectroscopy in an isolated perfused pig kidney model. J. Surg. Res.93, 1–8 (2000).
   PubMedGoogle Scholar
• Niemann CU, Choi S, Behrends M et al. Mild hypothermia protects obese rats from fulminant hepatic necrosis induced by ischemia-reperfusion. Surgery140, 404–412 (2006).
   Google Scholar
• Navarro VJ, Senior JR. Drug-related hepatotoxicity. N. Engl. J. Med.354, 731–739 (2006).
   PubMed Web of Science ®Google Scholar
• Bruinsma GJ, Van de Kolk CW, Nederhoff MG et al. Brain death-related energetic failure of the donor heart becomes apparent only during storage and reperfusion: an ex vivo phosphorus-31 magnetic resonance spectroscopy study on the feline heart. J. Heart Lung Transplant.20, 996–1004 (2001).
   PubMedGoogle Scholar
• Caus T, Kober F, Mouly-Bandini A et al. 31P MRS of heart grafts provides metabolic markers of early dysfunction. Eur. J. Cardiothorac. Surg.28, 576–580 (2005).
   PubMed Web of Science ®Google Scholar
• Niekisch MB, Von Elverfeldt D, Saman AE et al. Improved pretransplant assessment of renal quality by means of phosphorus-31 magnetic resonance spectroscopy using chemical shift imaging. Transplantation77, 1041–1045 (2004).
   PubMedGoogle Scholar
• Yoshikawa T, Suzuki Y, Kanashiro M et al. Objective and rapid assessment of pancreas graft viability using 31P-nuclear magnetic resonance spectroscopy combined with two- layer cold storage method. Transplantation78, 78–82 (2004).
   PubMedGoogle Scholar
• Franks SE, Smith MR, Arias-Mendoza F et al. Phosphomonoester concentrations differ between chronic lymphocytic leukemia cells and normal human lymphocytes. Leuk. Res.26, 919–926 (2002).
   PubMed Web of Science ®Google Scholar
• Carpinelli G, Carapella CM, Palombi L et al. Differentiation of glioblastoma multiforme from astrocytomas by in vitro 1H MRS analysis of human brain tumors. Anticancer Res.16, 1559–1563 (1996).
   PubMedGoogle Scholar
• Lehnhardt FG, Bock C, Rohn G et al. Metabolic differences between primary and recurrent human brain tumors: a 1H NMR spectroscopic investigation. NMR Biomed.18, 371–382 (2005).
   PubMedGoogle Scholar
• Maxwell RJ, Martinez-Perez I, Cerdan S et al. Pattern recognition analysis of 1H NMR spectra from perchloric acid extracts of human brain tumor biopsies. Magn. Reson. Med.39, 869–877 (1998).
   PubMedGoogle Scholar
• Tzika AA, Cheng LL, Goumnerova L et al. Biochemical characterization of pediatric brain tumors by using in vivoand ex vivo magnetic resonance spectroscopy. J. Neurosurg.96, 1023–1031 (2002).
   PubMedGoogle Scholar
• Nelson SJ. Analysis of volume MRI and MR spectroscopic imaging data for the evaluation of patients with brain tumors. Magn. Reson. Med.46, 228–239 (2001).
   PubMedGoogle Scholar
• Kurhanewicz J, Swanson MG, Wood PJ, Vigneron DB. Magnetic resonance imaging and spectroscopic imaging: improved patient selection and potential for metabolic intermediate endpoints in prostate cancer chemoprevention trials. Urology57, 124–128 (2001).
   PubMedGoogle Scholar
• Swanson MG, Vigneron DB, Tran TK et al. Single-voxel oversampled J-resolved spectroscopy of in vivo human prostate tissue. Magn. Reson. Med.45, 973–980 (2001).
   PubMedGoogle Scholar
• Glunde K, Ackerstaff E, Natarajan K et al. Real-time changes in 1H and 31P NMR spectra of malignant human mammary epithelial cells during treatment with the anti-inflammatory agent indomethacin. Magn. Reson. Med.48, 819–825 (2002).
   PubMedGoogle Scholar
• Mountford CE, Somorjai RL, Malycha P et al. Diagnosis and prognosis of breast cancer by magnetic resonance spectroscopy of fine-needle aspirates analysed using a statistical classification strategy. Br. J. Surg.88, 1234–1240 (2001).
   PubMedGoogle Scholar
• Katz-Brull R, Seger D, Rivenson-Segal D et al. Metabolic markers of breast cancer: enhanced choline metabolism and reduced choline-ether-phospholipid synthesis. Cancer Res.62, 1966–1970 (2002).
   PubMed Web of Science ®Google Scholar
• Bolan PJ, Meisamy S, Baker EH et al.In vivo quantification of choline compounds in the breast with 1H MR spectroscopy. Magn. Reson. Med.50, 1134–1143 (2003).
   PubMedGoogle Scholar
• Stanwell P, Gluch L, Clark D et al. Specificity of choline metabolites for in vivo diagnosis of breast cancer using 1H MRS at 1.5 T. Eur. Radiol.15, 1037–1043 (2005).
   PubMedGoogle Scholar
• Gottschalk S, Anderson N, Hainz C et al. Imatinib (STI571)-mediated changes in glucose metabolism in human leukemia BCR-ABL-positive cells. Clin. Cancer Res.10, 6661–6668 (2004).
   PubMed Web of Science ®Google Scholar
• Serkova N, Boros LG. Detection of resistance to imatinib by metabolic profiling: clinical and drug development implications. Am. J. Pharmacogenomics5, 293–302 (2005).
   PubMedGoogle Scholar
• Tugnoli V, Bottura G, Fini G et al. 1H-NMR and 13C-NMR lipid profiles of human renal tissues. Biopolymers72, 86–95 (2003).
   PubMedGoogle Scholar
• Lehtimaki KK, Valonen PK, Griffin JL et al. Metabolite changes in BT4C rat gliomas undergoing ganciclovir-thymidine kinase gene therapy-induced programmed cell death as studied by 1H NMR spectroscopy in vivo, ex vivo, and in vitro.J. Biol. Chem.278, 45915–45923 (2003).
   PubMedGoogle Scholar
• Boss EA, Moolenaar SH, Massuger LF et al. High-resolution proton nuclear magnetic resonance spectroscopy of ovarian cyst fluid. NMR Biomed.13, 297–305 (2000).
   PubMed Web of Science ®Google Scholar
• Brindle JT, Nicholson JK, Schofield PM et al. Application of chemometrics to 1H NMR spectroscopic data to investigate a relationship between human serum metabolic profiles and hypertension. Analyst128, 32–36 (2003).
   PubMed Web of Science ®Google Scholar
• Sabatine MS, Liu E, Morrow DA et al. Metabolomic identification of novel biomarkers of myocardial ischemia. Circulation112, 3868–3875 (2005).
   PubMed Web of Science ®Google Scholar
• Viant MR, Lyeth BG, Miller MG, Berman RF. An NMR metabolomic investigation of early metabolic disturbances following traumatic brain injury in a mammalian model. NMR Biomed.18, 507–516 (2005).
   PubMed Web of Science ®Google Scholar
• Noguchi Y, Sakai R, Kimura T. Metabolomics and its potential for assessment of adequacy and safety of amino acid intake. J. Nutr.133, S2097–S2100 (2003).
   Web of Science ®Google Scholar
• Manolio T. Novel risk markers and clinical practice. N. Engl. J. Med.349, 1587–1589 (2003).
   PubMed Web of Science ®Google Scholar
• Davis CD, Milner J. Frontiers in nutrigenomics, proteomics, metabolomics and cancer prevention. Mutat. Res.551, 51–64 (2004).
   PubMed Web of Science ®Google Scholar